Experimental prostate carcinogenesis - Rodent models

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 219-226

  Shirai, Tomoyuki ^a   Takahashi, Satoru ^a   Cui, Lin ^a   Futakuchi, Mitsuru ^a   Kato, Koji ^a   Tamano, Seiko ^a   Imaida, Katsumi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Prostate cancer; Rodent model

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2',3 DIMETHYL 4 BIPHENYLAMINE; ALPHA TOCOPHEROL; ANDROSTANOLONE; BIS(2 OXOPROPYL)NITROSAMINE; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CADMIUM; CARCINOGEN; DAIDZEIN; ESTROGEN; FLUTAMIDE; GAMMA ORYZANOL; GENISTEIN; HETEROCYCLIC AMINE; ISOFLAVONE; METHYLNITROSOUREA; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; RAT; REVIEW; RODENT; TRANSGENIC MOUSE;

MUS MUSCULUS; RODENTIA;

EID: 0034086024     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00039-9     Document Type: Article

References (52)

1. Hebert J.R., Hurley T.G., Olendzki B.C., Teas J., Ma Y., Hampl J.S. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J. Natl. Cancer Inst. 90:1998;1637-1647.
2. Cancer Statistics in Japan - 1997, T. Kakizoe (Eds.), Foundation of Promotion of Cancer Research, Tokyo, 1997, pp. 32-47.
3. Jesik C.J., Holland J.M., Lee C. An anatomic and histologic study of the rat prostate. Prostate. 3:1982;81-97.
4. N. Ito, T. Shirai, Tumours of the accessory male sex organs, in: V. Turusov, U. Mohr (Eds.), Pathology of Tumours in Laboratory Animals, 2nd edn., Vol. 1, Tumours of the Rat, IARC Scientific Publications No. 99, IARC, Lyon, France, 1990, pp. 421-444.
5. Rivenson A., Silverman J. The prostatic carcinoma in laboratory animals. A bibliographic survey from 1900 to 1977. Invest. Urol. 16:1979;468-472.
6. Reznik G., Ward J.M. Morphology of hyperplastic and neoplastic lesions in the clitoral and preputial gland of the F344 rat. Vet. Pathol. 18:1981;228-238.
7. Ward J.M., Reznik D., Stinson S.F., Lattuada C.P., Longfellow D.G., Cameron T.P. Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. Lab. Invest. 43:1980;517-522.
8. Pollard M. The Lobund-Wistar rat model of prostate cancer. J. Cell Biochem. Suppl. 16H:1992;84-88.
9. Pollard M., Luckert P.H. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system. Prostate. 11:1987;219-227.
10. Drago J.R. The induction of Noble rat prostatic carcinomas. Anticancer Res. 4:1984;255-256.
11. Bosland M.C., Prinsen M.K. Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2′-dimethyl-4-aminobiphenyl, after sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res. 50:1990;691-699.
12. Bosland M.C., Prinsen M.K., Kroes R. Adenocarcinomas of the prostate induced by N-nitroso-N-methylurea in rats pretreated with cyproterone acetate and testosterone. Cancer Lett. 18:1983;69-78.
13. Pour P.M. A new prostatic cancer model: systemic induction of prostatic cancer in rats by a nitrosamine. Cancer Lett. 13:1981;303-308.
14. Pour P.M., Stepan K. Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine. Cancer Res. 47:1987;5699-5706.
15. Katayama S., Fiala E., Reddy B.S., Rivenson A., Silverman J., Williams G., Weisburger J.H. Prostate adenocarcinoma in rats: induction by 3,2′-dimethyl-4-aminobiphenyl. J. Natl. Cancer Inst. 68:1982;867-873.
16. Shirai T., Sakata T., Fukushima S., Ikawa E., Ito N. Rat prostate as one of the target organs for 3,2′-dimethyl-4-aminobiphenyl-induced carcinogenesis: effects of dietary ethinyl estradiol and methyltestosterone. Jpn. J. Cancer Res. (Gann). 76:1985;803-808.
17. Ito N., Shirai T., Tagawa Y., Nakamura A., Fukushima S. Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2′-dimethyl-4-aminobiphenyl. Cancer Res. 48:1988;4629-4632.
18. Shirai T., Nakamura A., Fukushima S., Yamamoto A., Tada M., Ito N. Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2′-dimethyl-4-aminobiphenyl. Carcinogenesis. 11:1990;793-797.
19. Shirai T., Iwasaki S., Naito H., Masui T., Kato T., Imaida K. Dose dependence of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis. Jpn. J. Cancer Res. 83:1992;695-698.
20. Shirai T., Tamano S., Kato T., Iwasaki S., Takahashi S., Ito N. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2′-dimethyl-4-aminobiphenyl and testosterone propionate. Cancer Res. 51:1991;1264-1269.
21. Shirai T., Sano M., Imaida K., Takahashi S., Mori T., Ito N. Duration dependent induction of invasive prostatic carcinomas with pharmacological dose of testosterone propionate in rats pretreated with 3,2′-dimethyl-4-aminobiphenyl and development of androgen-independent carcinomas after castration. Cancer Lett. 83:1994;11-116.
22. Shirai T., Tamano S., Sano M., Imaida K., Hagiwara A., Futakuchi M., Takahashi S., Hirose M. Site-specific effects of testosterone propionate on the prostate of rat pretreated with 3,2′-dimethyl-4-aminobiphenyl: dose-dependent induction of invasive carcinomas. Jpn. J. Cancer Res. 86:1995;645-648.
23. Shirai T., Imaida K., Masui T., Iwasaki S., Mori T., Kato T., Ito N. Effects of testosterone, dihydrotestosterone and estrogen on 3,2′-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis. Int. J. Cancer. 57:1994;224-228.
24. Bosland M.C., Ford H., Horton L. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrol. Carcinogenesis. 16:1995;1311-1317.
25. Ofner P., Bosland M.C., Vena R.L. Differential effects of diethylstilbestrol and estradiol-17β in combination with testosterone on rat prostate lobes. Toxicol. Appl. Pharmacol. 112:1992;300-339.
26. Masui T., Shirai T., Imaida K., Hirose M., Futakuchi M., Tatematsu M., Ito N. Ki-ras mutations with frequent normal allele loss versus absence of p53 mutations in rat prostate and seminal vesicle carcinomas induced with 3,2′-dimethyl-4-aminobiphenyl. Mol. Carcinog. 13:1995;21-26.
27. Sukumar S., Armstrong B., Bruyntjes J.P., Leav I., Bosland M.C. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas. Mol. Carcinog. 4:1991;362-368.
28. Kato K., Takahashi S., Mori T., Futakuchi M., Cui L., Ito N., Shirai T. Establishment of transplantable rat prostate carcinomas from primary lesions induced by 3,2′-dimethyl-4-aminobiphenyl and testosterone. J. Toxicol. Pathol. 11:1998;27-32.
29. Nakanishi H., Takeuchi S., Kato K., Shimizu S., Kobayashi K., Tatematsu M., Shirai T. Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2′-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats. Jpn. J. Cancer Res. 87:1996;1218-1226.
30. Iwasaki S., Kato K., Mori T., Takahashi S., Futakuchi M., Shirai T. Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2′-dimethyl-4-aminobiphenyl and testosterone propionate. Jpn. J. Cancer Res. 90:1999;23-30.
31. Shirai T., Iwasaki S., Masui T., Mori T., Kato T., Ito N. Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2′-dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res. 84:1993;1023-1030.
32. Nakamura A., Shirai T., Takahashi S., Ogawa K., Hirose M., Ito N. Lack of modification by naturally occurring antioxidants of 3,2′-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis. Cancer Lett. 58:1991;241-246.
33. Tagawa Y., Shirai T., Fukushima S., Nakamura A., Hirose M., Ito N. Lack of modification by dietary unsaturated fat of 3,2′-dimethyl-4-aminobiphenyl-induced rat prostate and colon carcinogenesis. J. Toxicol. Pathol. 2:1989;49-53.
34. Tagawa Y., Ozaki K., Takahashi S., Ogawa K., Shirai T. Lack of effects of post-initiation cholesterol on 3,2′-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis. Prostate. 20:1992;179-186.
35. Shirai T., Fukushima S., Kawabe M., Shibata M.-A., Iwasaki S., Tada M., Ito N. Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2′-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. Carcinogenesis. 12:1991;1335-1339.
36. Tsukamoto S., Akaza H., Onozawa M., Shirai T., Ideyama Y. A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats. Cancer. 82:1998;531-537.
37. Onozawa M., Kawamori T., Baba M., Fukuda K., Toda T., Sato H., Ohtani M., Akaza H., Sugimura T., Wakabayashi K. Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Jpn. J. Cancer Res. 90:1999;393-398.
38. Shirai T., Imaida K., Iwasaki S., Mori T., Tada M., Ito N. Sequential observation of rat prostate lesion development induced by 3,2′-dimethyl-4-aminobiphenyl and testosterone. Jpn. J. Cancer Res. 84:1993;20-25.
39. Hasegawa R., Sano M., Tamano S., Imaida K., Shirai T., Nagao M., Sugimura T., Ito N. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenesis in rats. Carcinogenesis. 14:1993;2553-2557.
40. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6 phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
41. T. Shirai, S. Takahashi, S. Tamano, Preneoplasia and neoplasia of the rat male genital tract, in: P. Bannash, W. Gösner (Eds.), Pathology of Neoplasia and Preneoplasia in Rodents, EULEP Color Atlas, Schattauer, Stuttgart, New York, 1997, pp. 141-162.
42. Takahashi S., Tamano S., Hirose M., Kimoto N., Ikeda Y., Sakakibara M., Tada M., Kadlubar F.F., Ito N., Shirai T. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. Cancer Res. 58:1998;4307-4313.
43. Lin C., Takahashi S., Futakuchi M., Imaida K., Shirai T. Promotion effects of high dose of testosterone in the cooked food derived PhIP-induced rat prostate carcinoma. Proc. Jpn. Cancer Assoc. 50:1998;81.
44. Shirai T., Yamamoto A., Imaida K., Tamano S., Mori T., Hasegawa R. Lack of synergism among DMAB, BOP, and MNU in induction of carcinomas of the rat ventral prostate. Teratogen. Carcin. Mutagen. 12:1992;71-77.
45. Green J.E., Greenberg N.M., Ashendel C.L., Barrett J.C., Boone C., Getzenberg R.H., Henkin J., Matusik R., Janus T.J., Scher H.I. Workgroup 3: transgenic and reconstitution models of prostate cancer. Prostate. 36:1998;59-63.
46. Greenberg N.M.et al. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA. 92:1995;3439-3443.
47. Maroulakou I.G., Anver M., Garrett L., Green J.E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Sci. USA. 91:1994;11236-11240.
48. M.C. Bosland, T.C. Jones, Adenocarcinoma, prostate, rat, in: U. Mohr, R.D. Hunt (Eds.), Monographs on Pathology of Laboratory Animals, Springer, New York, 1987, pp. 253-260.
49. Shirai T., Yamamoto A., Iwasaki S., Tamano S., Masui T. Induction of invasive carcinomas of the seminal vesicles and coagulating glands of F344 rats by administration of N-methyl-nitrosourea or N-nitrosobis(2-oxopropyl)amine and followed by testosterone propionate with or without high-fat diet. Carcinogenesis. 12:1991;2169-2173.
50. Tamano S., Rehm S., Waalkes M.P., Ward J.M. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone. Vet. Pathol. 33:1996;557-567.
51. Flanders W.D. Review: prostate cancer epidemiology. Prostate. 5:1984;621-629.
52. Kanegae Y., Takamori K., Sato Y., Lee G., Nakai M., Saito I. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene. 181:1996;207-212.